Minaris is a global cell and gene therapy (CGT) CDMO and multimodal biosafety testing organization. With more than 25 years of CGT development and manufacturing expertise and more than 40 years in biosafety testing, Minaris combines deep legacy experience with state-of-the-art GMP facilities.

Headquartered in Switzerland with global operations, Space Peptides provides end-to-end pharmaceutical Peptide CRDMO services - covering discovery, process development, and GMP manufacturing. In addition, our portfolio comprises a broad range of generic Peptide APIs.

Pharmaron, founded in 2004, is a leading life sciences service provider offering research, development, and manufacturing across drug discovery and clinical development for small molecules, biologics, and CGT. With 22,000+ staff, it operates in China, the U.S., and the U.K.